Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109887

Phenolic and Tyrosyl Ring Deiodination of Iodothyronines in Rat Brain Homogenates

Michael M. Kaplan and Kimberlee A. Yaskoski

Thyroid Unit, Peter Bent Brigham Hospital Division of Affiliated Hospitals Center, and Harvard Medical School, Boston, Massachusetts 02115

Find articles by Kaplan, M. in: PubMed | Google Scholar

Thyroid Unit, Peter Bent Brigham Hospital Division of Affiliated Hospitals Center, and Harvard Medical School, Boston, Massachusetts 02115

Find articles by Yaskoski, K. in: PubMed | Google Scholar

Published September 1, 1980 - More info

Published in Volume 66, Issue 3 on September 1, 1980
J Clin Invest. 1980;66(3):551–562. https://doi.org/10.1172/JCI109887.
© 1980 The American Society for Clinical Investigation
Published September 1, 1980 - Version history
View PDF
Abstract

Conversion of thyroxine (T4) to 3,5,3′-triiodothyronine (T3) in rat brain has recently been shown in in vivo studies. This process contributes a substantial fraction of endogenous nuclear T3 in the rat cerebral cortex and cerebellum. Production of T4 metabolites besides T3 in the brain has also been suggested. To determine the nature of these reactions, we studied metabolism of 0.2-1.0 nM [125I]T4 and 0.1-0.3 nM [131I]T3 in whole homogenates and subcellular fractions of rat cerebral cortex and cerebellum. Dithiothreitol (DTT) was required for detectable metabolic reactions: 100 mM DTT was routinely used. Ethanol extracts of incubation mixtures were analyzed by paper chromatography in t-amyl alcohol:hexane:ammonia and in 1-butanol:acetic acid. Rates of production of iodothyronines from T4 and T3 were greater at pH 7.5 than at 6.4 or 8.6 and greater at 37°C than at 22° or 4°C. Lowering the pH, reducing the protein or DTT concentrations, and preheating homogenates to 100°C all increased excess I− production but reduced iodothyronine production.

In cerebral cortical homogenates from normal rats, products of T4 degradation were as follows (percent added T4±SEM in nine experiments): T3, 1.9±0.5%; 3,3′,5′-triiodothyronine (rT3), 34.0±2.4%; 3,3′-diiodothyronine (3,3′-T2), 5.8±1.6%; 3′-iodothyronine (3′-T1), ≤2.5%; and excess I−, 4.7±1.2%. In the same experiments, products of T3 degradation were 3,3′-T2, 63.3±5.5%, and 3′-T1, 12.6±1.4%. Cerebral cortical homogenates from hyperthyroid rats and normals were similar in regard to T4 to T3 deiodination. In contrast, in cerebral cortical homogenates from hypothyroid rats, phenolic ring deiodination rates were increased and tyrosyl ring deiodination rates were decreased compared with normals.

T4 to T3 conversion rates in cerebellar homogenates were greater than rates in cerebral cortical homogenates from the same normal rats and less than rates in cerebellar homogenates from hypothyroid rats. T4 and T3 tyrosyl ring deiodination rates were greatly diminished in cerebellar homogenates compared with cerebral cortical homogenates in normal and hypothyroid rats. High-speed (1,000-160,000 g) pellets from cerebral cortical homogenates were enriched in phenolic and tyrosyl ring deiodinating activities relative to cytosol. Fractional conversion of T4 to T3 was inhibited by T4, iopanoic acid, and rT3, but not by T3. Tyrosyl ring deiodination reactions were inhibited by T3, T4, and iopanoic acid, but not by rT3.

These studies demonstrate separate phenolic and tyrosyl ring iodothyronine deiodinase enzymes in rat brain. The brain phenolic ring deiodinase serves in vivo as a T4 5′-deiodinase and closely resembles anterior pituitary T4 5′-deiodinase in physiological and biochemical characteristics. The physiological significance of the tyrosyl ring iodothyronine deiodinase enzyme is unclear; it shares several properties with rat hepatic T4 5-deiodinase.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 551
page 551
icon of scanned page 552
page 552
icon of scanned page 553
page 553
icon of scanned page 554
page 554
icon of scanned page 555
page 555
icon of scanned page 556
page 556
icon of scanned page 557
page 557
icon of scanned page 558
page 558
icon of scanned page 559
page 559
icon of scanned page 560
page 560
icon of scanned page 561
page 561
icon of scanned page 562
page 562
Version history
  • Version 1 (September 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts